₹125.00
as on
as on September 8, 2025 at 4:01 pm IST
52 Week's Low
52 Week's High
29.56%
Downside
21.88%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹138.24 Cr
Return on Equity (ROE)
32.04
PE Ratio (TTM)
30.89
Return on capital employed (ROCE)
29.73
Industry PE ratio
42.41
Beta (LTM)
0.6
P/B Ratio
0Dividend Yield
0PEG Ratio
52.35
Quarterly Earnings Growth YOY
100
EPS (TTM)
3.24
Sector
Pharmaceuticals
Book Value
40.96
Technical Analysis
Bearish
View Technical Analysis
as on September 8, 2025 at 4:01 pm IST
Sotac Pharmaceuticals Ltd in the last 5 years
Lowest (13.14x)
April 24, 2023
Today (30.89x)
September 5, 2025
Industry (42.41x)
September 5, 2025
Highest (44.90x)
July 16, 2024
Today’s Price to Earnings Ratio: 30.89x
Compare market cap, revenue, PE, and other key metrics of Sotac Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 138.24 | 0.72% | 0.70 | 3 | 103 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Sotac Pharmaceuticals Ltd Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Sotac Pharmaceuticals Ltd.
Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 25.5 Cr → 27.8 Cr (in ₹), with an average increase of 8.3% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 8.88% to 15.12% in Mar 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.85% of holdings in Mar 2025 quarter
Price Dip
In the last 7 days, SOTAC stock has moved down by -4.3%
Retail Holding Down
Retail Investor have decreased holdings from 18.27% to 11.35% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, 1.64 Cr → 0.46 Cr (in ₹), with an average decrease of 39.9% per quarter
Organisation | Sotac Pharmaceuticals Ltd |
Industry | Pharmaceuticals |
CEO | Sharadkumar Dashrathbhai Patel |
E-voting on shares | Click here to vote |
Sotac Pharmaceuticals Ltd share price today stands at ₹125 as on at the close of the market. Sotac Pharmaceuticals Ltd share today touched a day high of ₹125 and a low of ₹125.
Sotac Pharmaceuticals Ltd touched a 52 week high of ₹152.35 and a 52 week low of ₹88.05. Sotac Pharmaceuticals Ltd share price today i.e. is closed at ₹125, which is -17.95% down from its 52 week high and 41.96% up from its 52 week low.
Sotac Pharmaceuticals Ltd market capitalisation is ₹138.24 Cr as on .
To buy Sotac Pharmaceuticals Ltd shares, you need to follow these steps:
Sotac Pharmaceuticals Ltd trading volume is 3,600.00 as on . This means that 3,600.00 shares of Sotac Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.